[
  {
    "ts": null,
    "headline": "Mizuho Upgrades Solventum (SOLV), Cites Optimistic Dental Outlook, Acera Acquisition",
    "summary": "Solventum Corporation (NYSE:SOLV) is one of the most profitable new stocks to buy right now. On January 20, Mizuho upgraded Solventum from Neutral to Outperform, raising its price target to $100 from $85. The firm’s decision is supported by its annual dental industry survey, which revealed a more optimistic outlook for consumables and patient volumes […]",
    "url": "https://finnhub.io/api/news?id=206bf8dd72a1781992eb0867c9bd678c0b794cb1273b5a4cf4d130b3457365f4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1770571111,
      "headline": "Mizuho Upgrades Solventum (SOLV), Cites Optimistic Dental Outlook, Acera Acquisition",
      "id": 138394472,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "SOLV",
      "source": "Yahoo",
      "summary": "Solventum Corporation (NYSE:SOLV) is one of the most profitable new stocks to buy right now. On January 20, Mizuho upgraded Solventum from Neutral to Outperform, raising its price target to $100 from $85. The firm’s decision is supported by its annual dental industry survey, which revealed a more optimistic outlook for consumables and patient volumes […]",
      "url": "https://finnhub.io/api/news?id=206bf8dd72a1781992eb0867c9bd678c0b794cb1273b5a4cf4d130b3457365f4"
    }
  }
]